Companies’ environmental, social and governance (“ESG”) narratives are increasingly important. The highly regulated life sciences and healthcare (“LSHC”) sector is often criticised for its high water and carbon usage, and its waste creation. LSHC companies are likely to come under increased scrutiny in this regard.
If ESG issues and risks are not managed effectively, the potential arises for regulatory enforcement, civil litigation, criminal sanctions, and reputational harm. LSHC companies and their legal advisers should be alive to these issues, and they should be incorporated into risk management strategies and monitored accordingly. We focus on three ‘litigation risk’ areas below.